IE
MEDS

Israel Englander’s DataMeds AI MEDS Stock Holding History

Israel Englander’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,391
Closed -$552K – 6573
2025
Q2 		$552K Buy
11,391
+6,988
+159% +$963K ﹤0.01% 4840
2025
Q1 		$951K Buy
+4,403
New +$743K ﹤0.01% 4380

Other funds holding MEDS

HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $388M AUM 22.18% 1-Year Est. Return

Israel Englander's MEDS Position: Q3 2025 in Review

Israel Englander sold out of DataMeds AI (MEDS) in Q3 2025, closing a stake of 11,391 shares — an estimated $552K sold.

Israel Englander first reported a position in MEDS in Q1 2025 and held it in 2 quarters. The position peaked at $951K in Q1 2025. 15 funds tracked by Wall St. Rank hold MEDS as of Q3 2025.

  • Israel Englander reported no remaining DataMeds AI position as of Q3 2025 after selling out during the quarter.
  • Israel Englander sold 11,391 DataMeds AI shares in Q3 2025, an estimated $552K.
  • Israel Englander first reported a position in DataMeds AI in Q1 2025 and held it in 2 quarters.
  • Israel Englander's DataMeds AI position peaked at $951K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held DataMeds AI as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.